AMENDED STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Company

Vir Biotechnology, Inc.

Filed

May 10, 2022

Period of Report

December 20, 2021

Accession Number

0001062993-22-012007